Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AMA To Lobby For Physician Disclaimer On All Direct-To-Consumer Drug Ads

Executive Summary

The American Medical Association will lobby federal drug regulators for all DTC pharmaceutical ads to include a disclaimer noting that doctors might suggest an alternate drug.

You may also be interested in...



FDA Preclearance Of DTC Ads Included In Sen. Kennedy Draft Bill

Repeat offenders of direct-to-consumer advertising regulations would be required to submit all future ads to FDA for preclearance under a draft bill sponsored by Sen. Edward Kennedy (D-Mass.)

FDA Preclearance Of DTC Ads Included In Sen. Kennedy Draft Bill

Repeat offenders of direct-to-consumer advertising regulations would be required to submit all future ads to FDA for preclearance under a draft bill sponsored by Sen. Edward Kennedy (D-Mass.)

AMA Urges Expanded FDA Funding For DTC Oversight; Ban On Ads Rejected

The American Medical Association will advocate increased funding for FDA to more closely monitor direct-to-consumer advertising under a policy adopted by the AMA House of Delegates Dec. 5 in Orlando.

Related Content

UsernamePublicRestriction

Register

PS038054

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel